Diabetes Self-Management – FDA Panel Votes in Favor of Inhalable Insulin; Diet Drug Recalled

April 5, 2014 | Permalink

On March 27, pharmaceutical manufacturer GlaxoSmithKline (GSK) Consumer Healthcare voluntarily recalled all nonprescription supplies of the weight-loss drug alli (generic name orlistat) from retailers in the United States and Puerto Rico due to tampering concerns.

Read more

Posted in Glucose & Insulin



  • Recent Posts